OccluNova Overview
- Year Founded
-
2023
- Status
-
Private
- Latest Deal Type
-
Series A
- (Cancelled)
- Investors
-
1
OccluNova General Information
Description
Developer of an implantable device for individuals with chronic atrial fibrillation. The company offers an innovative system that occludes the left atrial appendage, which prevents thrombus formation, enabling patients to discontinue lifelong oral anticoagulation therapy, reducing the risk of ischemic stroke.
Contact Information
Website
www.occlunova.comCorporate Office
- 6901 West Fish Lake Road
- Suite 100
- Maple Grove, MN 55369
- United States
Corporate Office
- 6901 West Fish Lake Road
- Suite 100
- Maple Grove, MN 55369
- United States
OccluNova Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | Cancelled | Clinical Trials - Phase 3 | ||||
| 1. Seed Round | 06-Nov-2025 | Completed | Clinical Trials - Phase 3 |
OccluNova Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NLC Health Ventures | Venture Capital | Minority |
OccluNova FAQs
-
When was OccluNova founded?
OccluNova was founded in 2023.
-
Where is OccluNova headquartered?
OccluNova is headquartered in Maple Grove, MN.
-
What industry is OccluNova in?
OccluNova’s primary industry is Therapeutic Devices.
-
Is OccluNova a private or public company?
OccluNova is a Private company.
-
What is OccluNova’s current revenue?
The current revenue for OccluNova is .
-
How much funding has OccluNova raised over time?
OccluNova has raised $150K.
-
Who are OccluNova’s investors?
NLC Health Ventures has invested in OccluNova.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process